|
FDA Reopens DTC Ad Rule Comment Period
Drugmakers have until Feb. 26 to submit additional comments on a proposed rule that establishes standards for the presentation of risk information in direct-to-consumer (DTC) television and radio advertisements.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives